- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04982731
Positive Assurance and mTBI
September 1, 2023 updated by: Inova Health Care Services
Developing and Evaluating a Positive Assurance Intervention on Recovery Outcomes in mTBI Patients
This study will develop and validate a new ED discharge educational video that provides positive assurance about mild traumatic brain injury (mTBI) recovery for patients with mTBI.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The research team will investigate the effect of this new ED Positive Assurance discharge intervention video on state anxiety and clinical recovery outcomes in pediatric patients with mTBI.
A sample of adolescent and young adult patients (13-21yrs) will be recruited for participation that present to the IFH Pediatrics ED (PED) with confirmed mTBI diagnosis and receive specialty referral to the Inova Sports Medicine Concussion Program for follow-up care.
Investigators will employ a randomized controlled trial (RCT) to enroll two groups of mTBI patients: 1) a group that receives the video intervention (EDUC), and 2) a group that receives standard discharge instructions (i.e., treatment as usual: TAU).
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christina Dollar, BS
- Phone Number: 571-472-0474
- Email: Christina.Dollar@inova.org
Study Contact Backup
- Name: R.J. Elbin, PhD
- Phone Number: 571-472-0462
- Email: Robert.Elbin@inova.org
Study Locations
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Recruiting
- Inova Health System
-
Contact:
- Christina Dollar, BS
- Phone Number: 571-472-0474
- Email: Christina.Dollar@inova.org
-
Contact:
- R.J. Elbin, PhD
- Phone Number: 571-472-0462
- Email: Robert.Elbin@inova.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 13-21 years
- Has sustained an external force to head or body resulting in neurological symptoms and at least one reported symptom is attributed to the mTBI (e.g., dizziness, confusion, headache, postural instability, light/noise sensitivity, nausea)
- Has receive a medical diagnosis of mTBI from an emergency physical at the IFH Pediatrics ED within 72 hours of injury
- Is able to provide informed written consent (parent) and assent
Exclusion Criteria:
- Loss of consciousness > 30 minutes in conjunction with the injury
- Glasgow Coma Scale (GCS) score < 13
- Has sustained a previous mTBI within the past 6 months
- Has a neurological disorder (e.g., epilepsy)
- Has a positive finding on brain imaging (e.g., CT, MRI) that suggests a severe closed head or open injury involving any structural damage or abnormality (e.g., fracture, subdural hematoma)
- Has a previous history of neurosurgery
- Does not speak English as a primary language
- Requires admission to the hospital
- Has developmental delays
- Prisoner
- Pregnant*
- Has been previously enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ED Positive Assurance Discharge Video Educational Intervention (EDUC).
The video intervention will be administered to participants that are randomly assigned to the EDUC group.
In addition, current standard of care discharge instructions will also be provided to the participant.
This EDUC intervention will consist of a brief, three to five-minute informative video message from the clinical neuropsychologist at the Inova Sports Medicine Concussion Program.
In addition to the viewing of the video after ED discharge, all participants will be instructed to view the video at least once every 24 - 48 hours prior to their visit to the concussion clinic.
|
Positive assurance is a low-cost, non-pharmacological strategy commonly used by specialty clinics to manage anxiety in individuals with mTBI.
Positive assurance is comprised of words of affirmation given to individuals with a medical condition by a healthcare provider that are centered on hope and positive recovery expectations (i.e., "You will recover," "This can be treated").
|
No Intervention: Standard of Care ED Discharge Instructions (Treatment as Usual: TAU )
The Acute Concussion Evaluation (ACE) Care plan in place at the Inova PED is the standard-of-care discharge instruction for individuals with mTBI.
This care plan provides patient and caregiver education about mTBI and emphasizes the monitoring of symptoms, signs of deterioration that may warrant urgent medical attention, and encourages the patient to follow up with their physician for follow up.
Participants who are randomized into the TAU group will receive this standard of care treatment in video format as well, however these participants will not be given a QR code to watch the intervention video.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavioral Regulation Assessment for Concussion (BRAC)
Time Frame: Gathered at Baseline Visit
|
The Behavioral Regulation Assessment for Concussion (BRAC) is a five-item, four-point Likert scale (with values ranging from '0-Never' to '5-Most of the Time') assessment for the frequency of self-reported behavioral regulation behaviors that occurred during the past seven days.
Scores range from 0 to 20, with higher scores indicating a better outcome.
Likert scale scores are reported for each item, with a higher score indicating greater frequency.
An average score for the BRAC is the average of all the scores across the items.
|
Gathered at Baseline Visit
|
Expectations of Recovery Scale
Time Frame: Gathered at Baseline Visit
|
The Expectations of Recovery Scale will be used to measure the effect of positive assurance on recovery.
This is a seven-item scale that asks individuals to assess whether they think they will get better soon, return to usual activities/work within the next month, return to the pre-injury performance and to consider what they had been told about their injury and what those closest to them advised.
Items within this scale are scored independently of each other, therefore neither higher nor lower scores indicate a better or worse outcome.
|
Gathered at Baseline Visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
State-Trait Anxiety Inventory (STAI)
Time Frame: Gathered at Baseline Visit and through study completion, an average of one month
|
The State-Trait Anxiety Inventory (STAI) will be used to assess state anxiety in participants ages 15 years and older.
The S-Anxiety scale (STAI Form Y-1) consists of twenty statements that are rated on a four-point Likert scale (1- not at all; 4 - very much so) that evaluate how respondents feel "right now, at this moment."
The T-Anxiety scale (STAI Form Y-2) consists of twenty statements rated on a four-point Likert scale (1- almost never; 4 - almost always) that assess how people generally feel.
Scores for both scales are continuous and range from 20-80, and clinical levels of state anxiety are classified with scores >40.
|
Gathered at Baseline Visit and through study completion, an average of one month
|
mTBI Symptoms
Time Frame: Gathered at Baseline Visit and through study completion, an average of one month
|
The Post-Concussion Symptom Scale (PCSS) will be used to assess mTBI symptoms.
This measure includes 22 symptoms (e.g., headache, nausea, dizziness, etc…) that are rated by the patient on a seven-point Likert scale (e.g., 0 = mild, 6 = severe).
Outcome scores for the PCSS are total number of reported symptoms (0 - 22) and total symptom severity score (0 - 132).
|
Gathered at Baseline Visit and through study completion, an average of one month
|
Immediate Post-concussion Assessment and Cognitive Test (ImPACT)
Time Frame: Gathered at Baseline Visit and through study completion, an average of one month
|
Investigators will assess cognitive function using the Immediate Post-concussion Assessment and Cognitive Test (ImPACT) computerized tool.
ImPACT assesses attention, visual working memory, verbal recognition memory, reaction time, visual processing speed, numerical sequencing ability, and learning.
|
Gathered at Baseline Visit and through study completion, an average of one month
|
Vestibular/Ocular Motor Screening (VOMS)
Time Frame: Gathered at Baseline Visit and through study completion
|
Investigators will use the Vestibular/Ocular Motor Screening (VOMS) tool to assess vestibular and ocular motor impairment via patient-reported symptom provocation.
The VOMS consists of the following five components: 1) smooth pursuits, 2) horizontal and vertical saccades, 3) convergence, 4) horizontal and vertical vestibular ocular reflex (VOR) and 5) visual motion sensitivity (VMS).
Self-reported symptom severities (0-10) are reported with each of the five components, with higher ratings reflecting greater symptom severity.
|
Gathered at Baseline Visit and through study completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2021
Primary Completion (Estimated)
August 31, 2024
Study Completion (Estimated)
August 31, 2025
Study Registration Dates
First Submitted
April 7, 2021
First Submitted That Met QC Criteria
July 27, 2021
First Posted (Actual)
July 29, 2021
Study Record Updates
Last Update Posted (Actual)
September 6, 2023
Last Update Submitted That Met QC Criteria
September 1, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U20-05-4050
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MTBI - Mild Traumatic Brain Injury
-
First Affiliated Hospital Xi'an Jiaotong UniversityHealth Science Center of Xi'an Jiaotong University; The Second Affiliated Hospital...RecruitingMTBI - Mild Traumatic Brain InjuryChina
-
Perception Dynamics InstituteUniversity of California, San Diego; University of South Alabama; University...RecruitingMTBI - Mild Traumatic Brain InjuryUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedConcussion, Mild | MTBI - Mild Traumatic Brain InjuryUnited States
-
Bispebjerg HospitalUniversity of Copenhagen; Synoptik-Fonden; IT University of Copenhagen; The Danish...RecruitingBrain Concussion | mTBI - Mild Traumatic Brain InjuryDenmark
-
Children's National Research InstituteCreare, Inc.RecruitingConcussion | MTBI - Mild Traumatic Brain InjuryUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedConcussion, Mild | MTBI - Mild Traumatic Brain InjuryUnited States
-
University of British ColumbiaUnknownConcussion | Sport-related Concussion | Mild Traumatic Brain Injury (MTBI)Canada
-
First Affiliated Hospital Xi'an Jiaotong UniversityXijing Hospital; Second Affiliated Hospital of Wenzhou Medical University; Central... and other collaboratorsRecruitingMTBI - Mild Traumatic Brain Injury | Moderate Traumatic Brain InjuryChina
-
University of AarhusCentral Denmark Region; Hammel Neurorehabilitation Centre and University Research...RecruitingConcussion, Mild | Post-Traumatic Headache | MTBI - Mild Traumatic Brain InjuryDenmark
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
Clinical Trials on Positive Assurance
-
University of UtahAgency for Healthcare Research and Quality (AHRQ)CompletedLow Back Pain | Sciatica | Physical TherapyUnited States
-
Dr. Derek ExnerUnknownMyocardial Infarction | Heart Failure | DeathCanada
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
Oregon Research InstituteStanford University; University of Texas at Austin; Trinity University, TexasCompletedEating DisorderUnited States
-
Aalborg UniversityCompletedPoint-of-care Ultrasonography (POCUS)Denmark
-
University Hospital, Gentofte, CopenhagenCompletedHepatic InsufficiencyDenmark
-
University of Alabama at BirminghamCompleted
-
Hebrew SeniorLifeNational Institute of Nursing Research (NINR)Completed
-
Mesoblast International SàrlNo longer availableModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19United States
-
University of Illinois at Urbana-ChampaignNational Heart, Lung, and Blood Institute (NHLBI)UnknownCardiovascular Risk Factor | Uncontrolled HypertensionUnited States